Compare LYEL & FIRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYEL | FIRY |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.8M | 190.8M |
| IPO Year | 2021 | 2020 |
| Metric | LYEL | FIRY |
|---|---|---|
| Price | $9.34 | $11.72 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $37.88 | N/A |
| AVG Volume (30 Days) | ★ 151.7K | 129.6K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $36,000.00 | ★ $104,496,000.00 |
| Revenue This Year | N/A | $22.11 |
| Revenue Next Year | N/A | $7.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 12.52 |
| 52 Week Low | $7.20 | $7.92 |
| 52 Week High | $45.00 | $14.12 |
| Indicator | LYEL | FIRY |
|---|---|---|
| Relative Strength Index (RSI) | 47.13 | 52.23 |
| Support Level | $7.20 | $9.31 |
| Resistance Level | $15.38 | $14.02 |
| Average True Range (ATR) | 0.73 | 0.68 |
| MACD | 0.26 | -0.19 |
| Stochastic Oscillator | 76.41 | 53.88 |
Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.
Firy Inc, formerly Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. Its reportable segments are: the Skillz segment and the RZR segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is a performance marketing platform that enables advertisers to acquire, retain, and monetize users across mobile, connected television (CTV), and other digital channels. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube, among others. It generates the majority of its revenue from the Skillz segment. Geographically, the company derives its key revenue from the United States.